CV Therapeutics to Redeem 4.75% Convertible Subordinated Notes Due 2007
Wednesday July 13, 7:00 am ET
PALO ALTO, Calif., July 13 /PRNewswire-FirstCall/ -- CV Therapeutics, Inc. (Nasdaq: CVTX - News) announced today that it will redeem on August 3, 2005 all of its outstanding 4.75% Convertible Subordinated Notes due March 7, 2007 (the "Notes"). The aggregate principal amount outstanding of the Notes is $79,645,000. The CUSIP numbers for the Notes are 126667AA2 and 126667AB0.
ADVERTISEMENT
On August 3, 2005, the Notes will be redeemed at a redemption price equal to 101.357% of the principal amount of the Notes, plus a cash payment equal to accrued and unpaid interest to the redemption date per $1,000 principal value of the Notes. Interest on the Notes will cease to accrue on the redemption date, and the only remaining right of the holders thereafter will be to receive the redemption payment, including accrued and unpaid interest to the redemption date.
A notice of redemption will be mailed by Wells Fargo Bank, National Association (successor in interest of Norwest Bank Minnesota, National Association), the trustee for the Notes, to all registered holders of the Notes. |
